Doximity stock drops 56% in 2026
Doximity’s stock has fallen significantly, down 56% in 2026, following the company’s fourth-quarter earnings report.
The decline is largely attributed to concerns over the impact of AI on the company’s operations.
Doximity’s ecosystem, however, remains strong, with over 85% of US physicians using the platform, and all top 20 pharmaceutical manufacturers as advertising customers.